Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

John Garibotto Joins Cellnovo's Board of Directors
Yahoo/PRNewswire
Saturday, June 22, 2013 - 10:13am
tags:
Management, devices, Cellnovo
Positive Data for COV's Pipeline
Yahoo/Zacks
Saturday, June 22, 2013 - 10:13am
tags:
pipeline, devices, Covidien
Proxy war raises pressure on Vivus to fatten Qsymia sales
Yahoo/Reuters
Saturday, June 22, 2013 - 10:12am
tags:
Vivus, Qsymia
ViiV Healthcare Partnership Anticipates New HIV Treatment Approval
Seeking Alpha
Saturday, June 22, 2013 - 10:09am
tags:
ViiV Healthcare, GSK, Pfizer, Shionogi, Dolutegravir, HIV
J&J’s Pump Automatically Adjusts Insulin for Diabetics
Bloomberg
Saturday, June 22, 2013 - 10:05am
tags:
diabetes, insulin pump
Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
Yahoo/PR NewsWire
Saturday, June 22, 2013 - 10:03am
tags:
Anthera
Novartis Heart Drug Receives FDA Designation to Expedite Review
Motley Fool
Saturday, June 22, 2013 - 9:59am
tags:
Novartis
Why Idenix Pharmaceuticals Shares Were Put in Time-Out Again
Motley Fool
Saturday, June 22, 2013 - 9:46am
tags:
Idenix, IDX20963, hepatitis C
Pfizer Announces FDA Acceptance for Review of Application to Expand Labeling for XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis to Include Inhibition of Progression of Structural Damage
Yahoo/BusinessWire
Saturday, June 22, 2013 - 9:44am
tags:
rheumatoid arthritis, Xeljanz, Pfizer
FDA Accepts New Drug Application And Creates A Catalyst For Durect Corporation
Seeking Alpha
Saturday, June 22, 2013 - 9:39am
tags:
Durect Corporation, Posidur, post-operative pain, pain management
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Friday, June 21, 2013 - 9:26am
tags:
diabetes, Merck, Januvia, Lantus, Sanofi, NovoRapid, Novo Nordisk, Eli Lilly, Humalog, Victoza, Levemir, Janumet, Novo Mix 30, Takeda, Actos
Ruconest Under FDA Review
Yahoo/Zacks
Friday, June 21, 2013 - 9:23am
tags:
Ruconest, FDA, Santarus, hereditary angiodema
Novartis Pregnancy Hormone Seen Lessening Heart Failures
Bloomberg
Friday, June 21, 2013 - 9:18am
tags:
Novartis, heart failure, RLX030
Idenix says FDA wants more safety data on experimental hepatitis C drug, delaying human trials
Yahoo/AP
Friday, June 21, 2013 - 9:16am
tags:
Idenix, FDA, hepatitis C, IDX20963
Summer Street 'much more optimistic' about MannKind approval
The Fly on the Wall
Friday, June 21, 2013 - 9:15am
tags:
MannKind, drug approvals, Afrezza, diabetes
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Friday, June 21, 2013 - 9:14am
tags:
Seattle Genetics, Adcetris, lymphoma
GlaxoSmithKline Settles Flonase Antitrust Suit
Courthouse News
Friday, June 21, 2013 - 8:59am
tags:
antitrust, GSK, Flonase
2 Big-Name Biopharma Catalysts For Second Half 2013
Seeking Alpha
Friday, June 21, 2013 - 8:58am
tags:
Amarin, Arena Pharmaceuticals, Belviq, Vascepa
Endo Health unit AMS to pay $54.5M in settlement
Yahoo/Fly on the Wall
Friday, June 21, 2013 - 8:56am
tags:
Endo Health Solutions, American Medical Systems, transvaginal mesh
Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
Forbes
Friday, June 21, 2013 - 8:54am
tags:
Eliquis, FDA, Pfizer, Bristol-Myers Squibb, anticoagulants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.